Neurol. praxi. 2026;27(4):313-318 | DOI: 10.36290/neu.2025.075

A rare case of progressive mitochondrial disease in childhood: a case report

MUDr. Stanislava Suroviaková, PhD.1, MUDr. Adam Markocsy, PhD.1, 3, MUDr. Matúš Igaz1, MUDr. Otília Petrovičová, PhD.1, 3, MUDr. Vladimír Zoľák, PhD.1, MUDr. Babeta Hofericová2, prof. MUDr. Peter Bánovčin, CSc.1, prof. MUDr. Miloš Jeseňák, PhD., MBA, Dott. Ric., MHA1, 3
1 Klinika detí a dorastu, Jesseniova lekárska fakulta v Martine, Univerzita Komenského v Bratislave, Univerzitná nemocnica Martin
2 Neurologická klinika, Jesseniova lekárska fakulta v Martine, Univerzita Komenského v Bratislave, Univerzitná nemocnica Martin
3 Ústav klinickej imunológie a lekárskej genetiky, Jesseniova lekárska fakulta v Martine, Univerzita Komenského v Bratislave, Univerzitná nemocnica Martin

Mitochondrial diseases are caused by dysfunction of mitochondrial DNA or its regulatory mechanisms. Mutations in the POLG gene, encoding mitochondrial DNA polymerase gamma, are the most common genetic cause of these disorders, leading to a broad spectrum of phenotypes. One of the most severe manifestations is Alpers-Huttenlocher syndrome (AHS), characterized by refractory epilepsy, progressive encephalopathy, and hepatic insufficiency. In this article, we present a case study of a 6-year-old female patient with a genetically confirmed homozygous POLG mutation who experienced a sudden onset of focal seizures with rapid neurological deterioration. Despite intensive treatment, the disease progressed to epilepsia partialis continua, multiple organ failure, and eventual death. This case highlights the phenotypic variability of POLG-associated disorders and the diagnostic challenges in their early recognition. The identification of characteristic EEG patterns and neuroimaging findings may be crucial for the timely diagnosis of patients suspected of having AHS.

Keywords: Alpers-Huttenlocher syndrome, epilepsy, mitochondria, POLG gene.

Received: June 8, 2025; Revised: October 9, 2025; Accepted: October 10, 2025; Prepublished online: October 10, 2025; Published: October 2, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Suroviaková S, Markocsy A, Igaz M, Petrovičová O, Zoľák V, Hofericová B, et al.. A rare case of progressive mitochondrial disease in childhood: a case report. Neurol. praxi. 2026;27(4):313-318. doi: 10.36290/neu.2025.075.
Download citation

References

  1. Anagnostou ME, Ng YS, Taylor RW, McFarland R. Epilepsy due to mutations in the mitochondrial polymerase gamma (POLG) gene: A clinical and molecular genetic review. Epilepsia. 2016;57(10):1531-1545. https://doi.org/10.1111/epi.13508. Go to original source... Go to PubMed...
  2. Boyd S, Harden A, Egger J, Pampiglione G. Progressive Neuronal Degeneration of Childhood with Liver Disease ("Alpers' Disease"): Characteristic Neurophysiological Features. Neuropediatrics. 1986;17(02):75-80. doi:10.1055/s-2008-1052505. Go to original source... Go to PubMed...
  3. Cohen BH, Chinnery PF, Copeland WC. POLG-Related Disorders. In: Adam MP. (Eds.) GeneReviews®. Seattle: University of Washington. 2010.
  4. Engelsen BA, Tzoulis C, Karlsen B, et al. POLG1 mutations cause a syndromic epilepsy with occipital lobe predilection. Brain: a journal of neurology. 2008;131(Pt 3):818-828. https://doi.org/10.1093/brain/awn007. Go to original source... Go to PubMed...
  5. Gonçalves FG, Hill B, Guo Y, et al. The Perirolandic Sign: A Unique Imaging Finding Observed in Association with Polymerase γ-Related Disorders. AJNR. American journal of neuroradiology. 2020;41(5):917-922. https://doi.org/10.3174/ajnr.A6514. Go to original source... Go to PubMed...
  6. Hikmat O, Eichele T, Tzoulis C, Bindoff LA. Understanding the Epilepsy in POLG Related Disease. Int J Mol Sci. 2017 Aug 24;18(9):1845. doi: 10.3390/ijms18091845. PMID: 28837072; PMCID: PMC5618494. Go to original source... Go to PubMed...
  7. Lim A, Thomas RH. The mitochondrial epilepsies. European journal of paediatric neurology: EJPN: official journal of the European Paediatric Neurology Society. 2020;24:47-52. https://doi.org/10.1016/j.ejpn.2019.12.02. Go to original source...
  8. McFarland R, Hudson G, Taylor RW, et al. Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase gamma (POLG1). Arch Dis Child. 2008;93:151-3. 10.1136/adc.2007.122911. Go to original source... Go to PubMed...
  9. Neeve VC, Samuels DC, Bindoff LA, et al. What is influencing the phenotype of the common homozygous polymerase-γ mutation p.Ala467Thr? Brain. 2012;135:3614-26. 10.1093/brain/aws298. Go to original source... Go to PubMed...
  10. Rahman S, Copeland WC. POLG-related disorders and their neurological manifestations. Nat Rev Neurol. 2019 Jan;15(1):40-52. doi: 10.1038/s41582-018-0101-0. PMID: 30451971; PMCID: PMC8796686. Go to original source... Go to PubMed...
  11. Saneto RP. Alpers-Huttenlocher syndrome: the role of a multidisciplinary health care team. J Multidiscip Healthc. 2016;9:323-33. 10.2147/JMDH.S84900. Go to original source...
  12. Saneto RP, Cohen BH, Copeland WC, Naviaux RK. Alpers-Huttenlocher syndrome. Pediatric neurology. 2013;48(3):167-178. https://doi.org/10.1016/j.pediatrneurol.2012.09.014. Go to original source... Go to PubMed...
  13. Suroviakova S, Zolak V, Igaz M, et al. COVID-19 Infection as a Possible Trigger for POLG-Related Mitochondrial Disease: A Case Report. Cureus. 2025;17(1):e77592. doi:10.7759/cureus.77592. Go to original source... Go to PubMed...
  14. Tzoulis C, Engelsen BA, Telstad W, et al. The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain. 2006;129:1685-92. 10.1093/brain/awl097. Go to original source... Go to PubMed...
  15. van Westrhenen A, Cats EA, van den Munckhof B, et al. Specific EEG markers in POLG1 Alpers' syndrome. Clinical neurophysiology: official journal of the International Federation of Clinical Neurophysiology. 2018;129(10):2127-2131. https://doi.org/10.1016/j.clinph.2018.07.016. Go to original source...
  16. Wolf NI, Rahman S, Schmitt B, et al. Status epilepticus in children with Alpers' disease caused by POLG1 mutations: EEG and MRI features. Epilepsia. 2009;50(6):1596-1607. https://doi.org/10.1111/j.1528-1167.2008.01877.x. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.